Products

Moxetumomab pasudotox (TAB-183-F(E))

Recombinant monoclonal antibody to CD22. Moxetumomab pasudotox is an anti-CD22 mouse monoclonal antibody designed for the treatment of cancer.      

Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
Mouse
Derivation
Mouse
Type
Fv - disulfide stabilized
Specificity
Tested positive against native human antigen.
Species Reactivity
Human
Applications
Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
CAS NO.
1020748-57-5
Generic Name
Moxetumomab pasudotox
M.W.
63.5 kDa
Related Disease
Hairy cell leukemia (HCL)
Target
Alternative Names
Moxetumomab pasudotox; 1020748-57-5; CAT-8015; HA22; R490A; BL22 immunotoxin; CD22; CD22 molecule
Entrez Gene ID
933
UniProt ID
P20273

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved